Pubblicato online: 16 mar 2023
Pagine: 35 - 40
Ricevuto: 17 nov 2022
DOI: https://doi.org/10.2478/rjim-2022-0022
Parole chiave
© 2023 Nikita Jhawar et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Testosterone therapy is commonly utilized to treat hypogonadism. After diagnosis with morning serum testosterone level in patients with symptoms of hypogonadism, therapy has been shown to improve symptoms. Research focusing on cardiovascular risks associated with testosterone therapy has produced contradictory statements. We review trials that have investigated the impact of testosterone supplementation on heart failure, coronary artery disease, and myocardial ischemia.